SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-10-13
👔
Retension Pharmaceuticals, Inc.
@Form4InsidersForm 4 Filing: Bisson Sabine Acquires shares of Retension Pharmaceuticals, Inc.
INSIDER ACQUISITION
⚡ MATERIALITY: 1/10
corporate issuer
Retension Pharmaceuticals, Inc.
Ticker: not matched
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-10-13
Shares: 4,115
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bisson Sabine, holds the title of CHIEF OPERATING OFFICER at Retension Pharmaceuticals, Inc..
On 2026-10-13, the insider transacted 4,115 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Bisson Sabine (CHIEF OPERATING OFFICER) transacted $0 of $RTSN
Post-Transaction Position: 1,611 shares
SEC Accession No: 0001213900-26-109156 (CIK: 2152874)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.